![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
CVS Caremark Makes Changes in Diabetes Coverage for 2025
2024年11月25日 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that …
UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
2024年10月3日 · UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.
Optum Rx Switches Up Humira Biosimilar Coverage for 2025
2024年12月9日 · Beginning Jan. 1, 2025, Optum Rx will prefer a different set of Humira biosimilar on its commercial formularies. UnitedHealth Group’s pharmacy benefit manager (PBM), one of …
Technology Emerges as Key Solution for Improving Specialty …
2024年10月21日 · Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their …
Aetna Updates MA and Drug Programs for Medicare in 2025
2024年10月1日 · In 2025, Aetna, the health insurance company of CVS Health, has added several new programs to Medicare for 2025. Aetna will launch new Chronic Condition Special …
Top 5 Podcast Episodes of 2024
2025年1月1日 · Loren McCaghy of Accenture Suggests Digital Engagement, Ease of Use as Key Drivers in Healthcare Provider and Payer Turnover In this latest episode of Tuning In to the C …
Prime Therapeutics Announces Rebranding, New Look
2024年9月16日 · Prime, headquartered in Eagan, Minnesota, is one of six largest pharmacy benefit managers (PBMs) in the country, an industry that has come under increasing criticism …
Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
2024年8月27日 · “In a clinical study, the 5 mg maintenance dose helped patients achieve an average of 15% weight loss after 72 weeks of treatment and has been a powerful tool for …
MHE January 2025 - managedhealthcareexecutive.com
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.
ICER: Potential New Pain Medication Offers Small Savings
2024年12月9日 · Suzetrigine, a non-opioid currently being reviewed by U.S. regulators to treat acute pain, would provide small savings and help patients avoid the use of opioids, according …